Cargando…
Therapeutic implications of ongoing alveolar viral replication in COVID-19
In patients with moderate-to-severe COVID-19 pneumonia, an aberrant post-viral alveolitis with excessive inflammatory responses and immunothrombosis underpins use of immunomodulatory therapy (eg, corticosteroids and interleukin-6 receptor antagonism). By contrast, immunosuppression in individuals wi...
Autores principales: | McGonagle, Dennis, Kearney, Mary F, O'Regan, Anthony, O'Donnell, James S, Quartuccio, Luca, Watad, Abdulla, Bridgewood, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635460/ https://www.ncbi.nlm.nih.gov/pubmed/34873587 http://dx.doi.org/10.1016/S2665-9913(21)00322-2 |
Ejemplares similares
-
COVID-19 vasculitis and novel vasculitis mimics
por: McGonagle, Dennis, et al.
Publicado: (2021) -
Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2022) -
Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
por: McGonagle, Dennis, et al.
Publicado: (2021) -
Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection
por: McGonagle, Dennis, et al.
Publicado: (2020) -
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
por: McGonagle, Dennis, et al.
Publicado: (2020)